Kline's study, NONPRESCRIPTION DRUGS CANADA 2006, reveals only 3% growth from 2005 for the overall OTC market, continuing a modest growth trend that has been prevalent since 1999.
Major pharmaceutical makers' nonprescription drug
divisions are expected to face tough business conditions, with health-conscious food and other products gaining popularity, industry analysts said.
Senate today passed S 3546, the "Dietary Supplement and Nonprescription Drug
Consumer Act," which would require manufacturers to notify the Food and Drug Administration (FDA) of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them.
Previously known as eFacts, the base application of the new version includes A to Z Drug Facts, Drug Facts and Comparisons, Drug Interaction Facts, the Drug Identifier, a drug identification tool, Herbal Interaction Facts, MedFacts Patient Information, Nonprescription Drug
Therapy, Review of Natural Products, and clinical tools including black box warnings, pregnancy and lactation warnings, investigational drugs, manufacturer index, orphan drugs, and normal lab values.
The 2006 edition of Kline's NONPRESCRIPTION DRUGS USA annual market analysis pegs the overall nonprescription drug
market in the United States at $16 billion for 2005.
It contains Drug Facts and Comparisons, The Review of Natural Products, Drug Interaction Facts, A to Z Drug Facts, Nonprescription Drug
Therapy, Cancer Chemotherapy Manual, Off-Label Drug Facts, Drug Interaction Facts: Herbal Supplements and Food, and Med Facts Patient Information.
3546, "Dietary Supplement and Nonprescription Drug
Consumer Act," a bill that would require manufacturers to notify FDA of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them.
Russia has recently prepared a videoreport that claimed that methadone is a nonprescription drug
in Kyrgyzstan," she noticed during the plenary session on September 25.
They explain the development of the Code of Ethics, its content, the foundations of ethical decision making, the steps of ethical analysis, the pharmacist-patient relationship, communication, prescription and nonprescription drug
distribution, issues like dealing with terminal illness and alternative medicines, and emerging concerns.
Such additional legislation includes the Dietary Supplement and Nonprescription Drug
Consumer Protection Act (2006), the FDA Amendments Act (2007) and the FDA Food Safety Modernization Act (2011).
J&J gained rights to the nonprescription drug
in its $16.
Available as a prescription drug since 2001, Zyrtec-D is now approved as a nonprescription drug
for the relief of symptoms due to hay fever or other upper respiratory allergies such as, runny nose, sneezing, itchy, watery eyes, itching of the nose or throat, and nasal congestion.